Trials / Sponsors / TCR2 Therapeutics
TCR2 Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant | Phase 1 / Phase 2 | 2022-06-21 |
| Completed | TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | 2020-03-27 |
| Active Not Recruiting | Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura | Phase 1 / Phase 2 | 2019-04-15 |